New advances in understanding the mechanisms and treatment challenges of ALK-targeted therapy resistance in lung cancer
{{output}}
Despite the development of various effective anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs), therapeutic resistance remains a major challenge. Both on-target and off-target mechanisms have been identified as key contributors to resistance. Wi... ...
